Literature DB >> 30814054

Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.

Sami Mamand1, Matthew Carr1, Rebecca L Allchin1, Matthew J Ahearne1, Simon D Wagner1.   

Abstract

Entities:  

Year:  2019        PMID： 30814054      PMCID： PMC6418494          DOI： 10.1182/bloodadvances.2018027821

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  24 in total

1.  Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells.

Authors:  Kristina T Lu; Yuka Kanno; Jennifer L Cannons; Robin Handon; Paul Bible; Abdel G Elkahloun; Stacie M Anderson; Lai Wei; Hongwei Sun; John J O'Shea; Pamela L Schwartzberg
Journal:  Immunity       Date:  2011-10-20       Impact factor: 31.745

Review 2.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

3.  The development and fate of follicular helper T cells defined by an IL-21 reporter mouse.

Authors:  Katja Lüthje; Axel Kallies; Yoko Shimohakamada; Gabrielle T Belz; Amanda Light; David M Tarlinton; Stephen L Nutt
Journal:  Nat Immunol       Date:  2012-05       Impact factor: 25.606

Review 4.  Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.

Authors:  Jinfang Zhu; William E Paul
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.

Authors:  Tianjiao Wang; Ye Lu; Avery Polk; Pinki Chowdhury; Carlos Murga-Zamalloa; Hiroshi Fujiwara; Koichiro Suemori; Niklas Beyersdorf; Alexandra C Hristov; Megan S Lim; Nathanael G Bailey; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2016-10-25       Impact factor: 12.531

6.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

Authors:  Laurence de Leval; David S Rickman; Caroline Thielen; Aurélien de Reynies; Yen-Lin Huang; Georges Delsol; Laurence Lamant; Karen Leroy; Josette Brière; Thierry Molina; Françoise Berger; Christian Gisselbrecht; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

7.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

8.  T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells.

Authors:  K Q Liu; S C Bunnell; C B Gurniak; L J Berg
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

Review 9.  Targets for Ibrutinib Beyond B Cell Malignancies.

Authors:  A Berglöf; A Hamasy; S Meinke; M Palma; A Krstic; R Månsson; E Kimby; A Österborg; C I E Smith
Journal:  Scand J Immunol       Date:  2015-09       Impact factor: 3.487

10.  Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.

Authors:  Sami Mamand; Rebecca L Allchin; Matthew J Ahearne; Simon D Wagner
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.